Effectiveness and Safety of Tisagenlecleucel Therapy in Brazilian Patients With B-lymphocyte Malignancies

Clinical trial NCT05541341 · RECRUITING

Trial details

NCT number: NCT05541341
Sponsor: Novartis Pharmaceuticals
Status: RECRUITING
Study type: OBSERVATIONAL

Diffuse Large B-cell Lymphoma Acute Lymphoblastic Leukemia Follicular Lymphoma

Start date: 2023-11-23
Primary completion: 2043-11-23
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.